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Rui-Min Ma, Lin Lv, Shu-Rong Zheng, Jie You, Du-ping Huang and Gui-Long Guo*Abstract
Background: Ectopic substernal thyroid is a rare symptom of thyroid disease that entirely results from the
developmental defects at early stages of thyroid embryogenesis and during its descent. Cases were seldom reported
as primary ectopic substernal thyroid cancer, especially those with severe local invasion and tracheal relapse.
Case Presentation: In this report, the patient presented odynophagia and a sense of progressing swallowing
obstruction. She underwent total thyroidectomy and lump resection. However, she refused to use postoperative
radioactive iodine or take adjuvant external-beam radiotherapy, except for thyroid hormone replacement therapy.
Tracheal relapse was observed after 6 months. Tracheal stent was used to reconstruct the airway twice.
Conclusions: Trachea invasion might be a worse independent predictor of prognosis than any others and
should be given particular attention. Furthermore, tracheal stent might be a palliative option for patients with
tracheal relapse.
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Thyroid cancer originates in thyroid tissue. It is common
but not deadly [1]. The 20-year disease-free survival is
about 90 % after operation [2]. Thyroid cancer can be
easily identified through ultrasound test or physical
examination. However, all optimistic results mentioned
above are connected to eutopic thyroid cancers (>99 %)
[2]. When thyroid cancer originates ectopically, it would
be difficult to diagnose apace [3].
Ectopic thyroid is reported in approximately 1 per
100,000–300,000 individuals and entirely results from
the developmental defects at early stages of thyroid
embryogenesis and during its descent [4]. Occurrences
in the substernum and mutation to cancer of ectopic
thyroid are extremely rare. In this paper, we report a
case of primary ectopic substernal thyroid cancer with
severe local invasion.* Correspondence: guoguilong930@163.com
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A 67-year-old woman was admitted with a 2-month
medical history of odynophagia and a sense of progressing
swallowing obstruction. She denied the other medical
history, except for hypertension, which she had controlled
well by pills. Her physical examination was normal, except
for a tracheal shift. Doppler ultrasound on the neck
revealed bilateral thyroid nodules and a substantive bump
at the entrance of the thorax. Chest radiograph showed a
tracheal shift (Fig. 1). Enhanced computed tomography
(CT) scan of the neck noted a large substantive mass
below the right lower pole of the thyroid with calcifica-
tion, and two lobes of the thyroid both had nodules
without any hint of lymph nodes (Fig. 2a). Core needle
biopsy and immunohistochemistry revealed papillary
thyroid cancer (PTC).
The positron emission tomography-computed tomog-
raphy (Fig. 3) indicated that the lump from the thoracic
inlet area to upper mediastinum had high metabolism,
and malignant neoplasm should be considered. More-
over, the tumor, along with surrounding invasion,
caused the trachea to migrate to the left. However, the
metabolic image of the mediastinal and hilar lymphistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Chest radiograph: the trachea was shifted to the left, and
there was mass or something faintly looming
Fig. 2 Computed tomography (CT). a Before surgery: enhanced CT scan
noted a large substantive mass around the right common carotid artery
bifurcation. b Six months after surgery: CT scan showed the trachea
narrowed, in the level of the thoracic inlet, next to the silver clips
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sides of the thyroid might also favor nodular goiter.
Laryngoscopy showed right vocal cord paralysis. The
bronchoscopy and cytopathology of the brush fluid
were normal (Fig. 4). The tumor mark and thyroid
function tests were almost normal.
After all the examinations, we still had no idea
whether the mass metastasized to the substernum or
originated there. We opted to diagnose after excision.
During operation, we found multiple nodules in both
sides of the thyroid, as well as the mass, which was right
behind the sternum, outside of the trachea and inside of
the right carotid artery. The mass was an observed
invasion of the trachea, carotid artery, and the recurrent
laryngeal nerve. And, it was so conglutinated with the
right carotid artery that it could not be removed
completely. Thus, we firstly took total thyroidectomy
with cervical lymph dissection of the right VI area. S-
ubsequently, we used sternotomy to excise more of the
lump after separating it from the local (right carotid
artery, trachea, and recurrent laryngeal nerve) gradually;
silver clips were left to mark the residual cavity in
preparation for radiotherapy. Postoperative pathology
confirmed that the lump was primary ectopic substernal
papillary thyroid cancer, and the eutopic thyroid was
nodular goiter. After surgery, the patient had an excellent
recovery.
However, she refused to use postoperative radioactive
iodine (RAI) or take adjuvant external-beam radiotherapy
(EBRT), which had been planned before surgery. Instead,
she took Euthyrox (100 mg every morning) for relapse
prevention.
Six months later, she complained of dyspnea. CT showed
that the trachea narrowed in the level of the thoracic inlet,
next to the silver clips (Fig. 2b). Bronchoscopy confirmed
that it was blocked by something new, and pathological
diagnosis revealed that it came from thyroid cancer but
was poorly differentiated. Tracheal stent was inserted via
bronchoscopy to reconstruct the airway for free respiration
(Fig. 5a, before stenting; Fig. 5b, after stenting). After
another 6 months of using Euthyrox, a second tracheal
stent was inserted because of recurring dyspnea (Fig. 5c,
before stenting; Fig. 5d, after stenting).
Discussion
After diagnosis and treatment of this woman, the following
points were obtained.
Part. 1 Whether adjuvant RAI or EBRT should be taken?
A patient with PTC usually has an exciting 5-year
overall survival rate (OS) of 97.5 % [5]. But, some
risk factors for recurrence and death still exist. The
most correlative factors affecting mortality are max-
imum tumor diameter (≥4), pre-operative neck gross
Fig. 3 PET-CT revealed a high metabolic tumor under sternal bone
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Postoperative RAI should generally be administered for
these variants as they will generally be intermediate to
advanced tumors [5]. In addition, old age ≥45, surround-
ing invasion, distant metastases, and gross locoregional
residual are indicators to perform adjuvant EBRT [7].
EBRT will improve their survival and reduce the recurrent
rate (51 % control group vs. 8 % EBRT group) [8]. The
toxicity-related side effects of EBRT, such as skin reaction,
esophagitis, and laryngeal irritation, are limited and
resolved during follow-up [9].
In our case, the patient is a 57-year-old woman, and the
tumor invaded the surroundings, such as trachea, right ca-
rotid artery, and right recurrent laryngeal nerve. It became
even worse while the tumor cannot be completely excised
because of the severe invasion in the right carotid artery.
Depending on all of the above, RAI and EBRT are neces-
sary for the patient just after the surgery.
However, tracheal relapse was poorly differentiated,
and the RAI therapy had lost the opportunity to benefit.Fig. 4 a Laryngoscopy showed an immobile vocal cord. b Bronchoscopy fPart. 2 Should we excise the invaded common carotid
artery?
The excision of big arteries was taken into account when
the tumor invaded the vessels so severely that it cannot be
removed completely alone. Therefore, a better option
should be selected between postoperative radiation therapy
without excision of the carotid artery and replacement
surgery of vessels.
The prognosis of those who have local invasion is
worse than those who do not. Vessel invasion is a pre-
dictable index [10]. Nevertheless, many complications
peri-operatively and postoperatively are present for
this index, such as neurologic sequelae, graft infection
or occlusion, and cerebral ischemia. Embolization and
hemorrhage also cannot be ignored [11]. Hence,
whether to reconstruct the invaded vessels or not is a
dilemma.
We searched the PubMed database, but there are few
literatures about the controversy, in addition to cases
involving vessel reconstruction along with thyroidound nothing abnormal
Fig. 5 a Before stenting, the neoplasm narrowed nearly 70 % of the lower trachea. b After stenting, the airway was reconstructed for free
respiration. c Before stenting, the neoplasm narrowed nearly 75 % of the airway at the second time just above the trachea carina. d After
stenting, the airway was reconstructed for the second time
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term metastasis and locoregional recurrence with vascular
invasion artery resection and reconstruction [12, 13].
However, other studies show that patients with T4
tumors can also have a good 5-year OS after adjuvant
RAI and EBRT therapies [8]. Furthermore, locoregional
failures all occur at the neck node area [9]. OS is not
significantly different from those re-operated within
cervical lymph node metastasis [14].
In our case, the common carotid artery was invaded,
but no obvious tumor-induced blockage was observed
(Fig. 3). Considering that the patient should take RAI and
EBRT therapies, which depended on severe local invasion
and old age (≥45), we opted for a milder surgery therapy
after obtaining the family’s approval and consent.
Unfortunately, the patient refused the therapy after
surgery. Nonetheless, the cervix condition was not too
bad, and no distant metastasis was observed.
Part. 3 Should we excise the invaded trachea and
reconstruct it?
Tracheal invasion, one third of the extrathyroidal exten-
sion, is an independent predictor of death, followed by
hemoptysis and dyspnea, in approximately 6 % of thyroid
cancer [15]. The status of trachea invasion can be dividedinto several stages. Stage A disease invades through the
capsule of the thyroid gland and invades the external
perichondrium of the trachea. Stage B disease invades
between the rings of cartilage or causes minor cartil-
age destruction. Stage C disease invades through the
cartilage or between the cartilaginous rings into the
lamina propria of the tracheal mucosa or in the sub-
mucosal area. Stage D disease is a full-thickness inva-
sion with the expansion of tracheal mucosa that is
visible through a bronchoscope as a nodule or ulcer-
ated mass [16]. Generally, the patients without re-
sidual have the greatest prognosis [17]. The patients
with stage A invasion have an almost identical prog-
nosis after shaving resection compared to segmental
tracheal resection.
This woman with stage A trachea invasion in our case
had shaving resection because of the granted adjuvant
RAI and EBRT therapy. She refused the adjuvant therapy,
and the gross relapsed through the trachea without having
invaded the common carotid artery and other distant
metastasis. Interestingly, the tumor invaded through the
trachea faster than the artery, which had been invaded
and had not been excised with all invasion tissues. Shaving
resection may have destroyed the tracheal anatomy and
made it easier to invade through than before. However,
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ing shaving resection, even the survival period of having
palliative surgery, are much better than those without any
airway operation in the patients of locally invaded thyroid
cancer. Hence, trachea invasion might be a worse
independent predictor of prognosis than any other local in-
vasion. Therefore, aggressive procedures should be
performed to protect the patient from relapsing. If tracheal
relapse occurs, the stent might solve the respiration
problem safely. Stent can be used a few times to release the
patient’s dyspnea and fear.
Conclusions
Primary ectopic substernal thyroid cancer is rare. When it
happens, its local condition should be considered carefully.
If the common carotid artery is involved, the adjuvant RAI
and EBRT should be undertaken to get better OS. If
the trachea is invaded, then aggressive surgical proce-
dures should be considered, such as full-thickness win-
dow resection or segmental tracheal resection, instead
of shaving resection. Tracheal stent might also be a
palliative option for a patient who has tracheal relapse
and cannot be removed.
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